Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

TCG Crossover

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 12
Average round size
info
The average size of a deal this fund participated in
$121M
Portfolio companies 12
Lead investments 1
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of TCG Crossover:
Typical Co-investors
TCG Crossover is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after TCG Crossover:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Alexa Fund Seattle, United States, Washington
Archimedes Labs California, Palo Alto, United States
Asheville Angels Asheville, North Carolina, United States
BOND New York, New York, United States
Brio Capital Management New York, New York, United States
Candy Ventures Luxembourg, Luxembourg
Cboe FX Markets New York, New York, United States
Crabtree & Evelyn Connecticut, United States, Woodstock
Derbi Foundation Bangalore, India, Karnataka
Emergent Game Technologies Calabasas, California, United States
Gray Ventures Atlanta, Georgia, United States
iDo Fund -
Industrial Bank China, Foochow, Fujian
Momo Beijing, Beijing, China
Motian Star China, Guangdong, Shenzhen
Pentech Ventures City of Edinburgh, Scotland, United Kingdom
Puget Sound Venture Club Bellevue, United States, Washington
Qianhai Zhongwei Capital China, Guangdong, Shenzhen
Shenshang Xingye Fund -
Slack Venture Capital England, Nottingham, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Upstream Bio

Health Care
Pharmaceutical
$200M02 Jun 2022 Waltham, Massachusetts, United States

Plexium

Biotechnology
Health Care
Medical
Pharmaceutical
Therapeutics
$102M23 Feb 2022 San Diego, California, United States

Arbor Biotechnologies

Biopharma
Biotechnology
Life Science
$215M09 Nov 2021 Cambridge, Massachusetts, United States

ShouTi

Biotechnology
Health Care
Medical
Pharmaceutical
Product Research
$100M20 Oct 2021 Shanghai, China

Alpine Immune Sciences

Biotechnology
Health Care
Medical
$91M15 Sep 2021 Seattle, Washington, United States

Artios Pharma

Biopharma
Biotechnology
Medical Device
$150M27 Jul 2021 Cambridge, England, United Kingdom

RayzeBio

Biotechnology
Health Care
Medical Device
Pharmaceutical
$108M15 Jun 2021 San Diego, California, United States

Synthekine

Biotechnology
Therapeutics
$107M10 Jun 2021 California, United States

Magenta Therapeutics

Biotechnology
Medical
Therapeutics
$86M12 May 2021 Cambridge, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent TCG Crossover?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: